Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs FR. et al, (2024), Journal of Infection, 89
FOUND Trial: randomised controlled trial study protocol for case finding of obstructive sleep apnoea in primary care using a novel device
Miller MA. et al, (2024), BMJ Open, 14
D-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial
Hayward G. et al, (2024), JAMA Internal Medicine, 184, 619 - 628
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
Parker CC. et al, (2024), The Lancet, 403, 2416 - 2425
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hayward G. et al, (2024), Journal of Infection, 88
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial
Freeman D. et al, (2022), Schizophrenia Research, 250, 50 - 59
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Altunkaya J. et al, (2022), Journal of medical Internet research, 24
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial
Wang K. et al, (2021), European Respiratory Journal, 58
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
PRINCIPLE Trial Collaborative Group None. et al, (2021)
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
PRINCIPLE Collaborative Group None. et al, (2021)